Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity
Tài liệu tham khảo
Bruun, 2005, MCP-1 release is higher in visceral than subcutaneous human adipose tissue. Implication of macrophages resident in the adipose tissue, J Clin Endocrinol Metab, 4, 2282, 10.1210/jc.2004-1696
Malavazos, 2005, Monocyte chemoattractant protein 1 (MCP-1) and visceral fat, J Clin Endocrinol Metab, 90, 3128, 10.1210/jc.2005-0424
Morricone, 2002, Echocardiographic abnormalities in normotensive obese patients: relationship with visceral fat, Obes Res, 10, 489, 10.1038/oby.2002.67
Marfella, 2004, Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women, Diabetes Care, 27, 47, 10.2337/diacare.27.1.47
Malavazos, 2005, Monocyte chemoattractant protein 1: a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity, Eur J Endocrinol, 153, 871, 10.1530/eje.1.02033
Jones, 2002, The role of soluble receptors in cytokine biology: the agonistic properties of the SIL-6R/IL-6 complex, Biochim. Biophys. Acta, 1592, 251, 10.1016/S0167-4889(02)00319-1
Hirota, 1995, Continuous activation of gp 130, a signal-transducing receptor component for interleukin-6-related cytokines, causes myocardial hypertrophy in mice, Proc Natl Acad Sci, 92, 4862, 10.1073/pnas.92.11.4862
Iacobellis, 2003, Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction, Obes Res, 11, 304, 10.1038/oby.2003.45
Iacobellis, 2004, Relation between epicardial adipose tissue and left ventricular mass, Am J Cardiol, 94, 1084, 10.1016/j.amjcard.2004.06.075
Mazurek, 2003, Human epicardial adipose tissue is a source of inflammatory mediators, Circulation, 108, 2460, 10.1161/01.CIR.0000099542.57313.C5
Baker, 2006, Human epicardial adipose tissue expresses a pathogenetic profile of adipocytokines in patients with cardiovascular disease, Cardiovasc Diabetol, 5, 1, 10.1186/1475-2840-5-1